Argenx
ARGX
#571
Rank
โ‚ฌ34.60 B
Marketcap
578,76ย โ‚ฌ
Share price
1.54%
Change (1 day)
28.11%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Net assets

Net assets on the balance sheet as of June 2024 : โ‚ฌ4.07 Billion

According to Argenx 's latest financial reports the company has โ‚ฌ4.07 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Argenx - Net assets on balance sheet (from 2013 to 2020)

Net assets by year

Year Net assets Change
2020-12-31$โ‚ฌ1.67 B41.82%
2019-12-31$โ‚ฌ1.18 B91.66%
2018-12-31$โ‚ฌ0.61 B48.83%
2017-12-31$โ‚ฌ0.41 B520.87%
2016-12-31$โ‚ฌ66.65 M63.54%
2015-12-31$โ‚ฌ40.75 M-33.08%
2014-12-31$โ‚ฌ60.9 M103.19%
2013-12-31$โ‚ฌ29.97 M79.99%
2012-12-31$โ‚ฌ16.65 M-40.31%
2011-12-31$โ‚ฌ27.89 M172.65%
2010-12-31$โ‚ฌ10.23 M